Managing Oncology Trials in the Era of COVID-19 Webinar May 27th, 2020

As COVID-19 continues to change the clinical trial landscape, innovations in site and patient engagements will help determine the success of oncology trials.

Join us for our upcoming webinar with Dr. Ari VanderWalde, a member of George Clinical’s scientific leadership team with oncology clinical research expertise, May 27th.

This webcast will give the oncology community an in-depth understanding of preparing safe and efficient trials and implementing best practices to mitigate disruption during COVID-19 restrictions.

Topics covered in this webinar include:

  • Explore the various risks and benefits of patients with cancer receiving oncology care during COVID-19
  • Review strategic considerations for undertaking new cancer clinical trials during the pandemic
  • Plan for how research will change under the “new normal”


The session will be streamed live on: May 27, 11:00 am USA CDT


George Clinical's Leadership in Attendance

Dr. VanderWalde specializes in melanoma and is experienced in genomic tumor assessment, public health, tumor immunotherapy, medical ethics and precision oncology. He is the Global Head of Clinical Research at Caris Life Sciences and works as Research Faculty at West Cancer Center where he served as the Director of Research from 2014 to 2021. He is also Professor in the Division of Epidemiology at the University of Memphis School of Public Health. Dr. VanderWalde has extensive experience in clinical research, including the design and conduct of clinical trials, results reporting, regulatory filing and interactions between investigators and the pharmaceutical industry. 

Event Location

Zoom Webinar

Attending this event?

Meet with George Clinical! Contact us to schedule a time now.

    I agree to the handling of my personal information in accordance with the George Clinical privacy policy.

    Please input this code: captcha

    Add George Clinical to your network